Loading clinical trials...
Loading clinical trials...
The purpose of this study is to select a suitable dose of BPS804 by measuring the strength/quality of bone using a special type of CT scanner. Participants will be treated for 12 months and followed u...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ultragenyx Pharmaceutical Inc
Collaborators
NCT05559801 · Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III
NCT01061099 · Osteogenesis Imperfecta Type II, Osteogenesis Imperfecta Type III
Mereo Investigator Site
Birmingham, Alabama
Mereo Investigator Site
Jacksonville, Florida
Mereo Investigator Site
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions